openPR Logo
Press release

Biotage Announces Peptide Research Collaboration with the Laboratory of Peptide and Protein Chemistry and Biology in Florence, Italy

06-03-2011 08:28 AM CET | Science & Education

Press release from: Biotage

Biotage Announces Peptide Research Collaboration with

Uppsala, Sweden, June 01, 2011 -- Biotage (STO: BIOT), a leading supplier of tools and technology for analytical and medicinapl chemistry, announced a collaborative research agreement with The Laboratory of Peptide & Protein Chemistry & Biology (PeptLab) located in Florence, Italy. The renowned peptide research facility, led by Professor Anna Maria Papini, has agreed to contribute technical input towards the future development of Biotage related products as well as provide training facilities for demonstrating Biotage’s range of peptide synthesis, purification and resin products.

PeptLab is an interdepartmental structure of the University of Florence, located at the Polo Scientifico e Tecnologico in Sesto Fiorentino, founded in 2004 by Professor Paolo Rovero (Dept. of Pharmaceutical Sciences), Professor Anna Maria Papini and Dr. Mario Chelli (Dept. of Organic Chemistry ‘Ugo Schiff’), and Professor Francesco Lolli (Dept. of Neurological Sciences).

Since 2009, the PeptLab proof-of-concept incorporated the French Laboratory, SOSCO of the University of Cergy-Pontoise (where expertise in glycol-chemistry and fluorine chemistry are present). This was made possible thanks to a Chaire d'Excellence provided to Prof. Papini and financial support from the French Agence Nationale de la Recherche, with the idea of organizing a European Innovation Network to introduce a “Quality Approach” as an innovative strategy for R&D activities in Academic Laboratories and SMEs, providing Good Practice Guidance initially in the field of peptide-based diagnostics.

“Biotage is very fortunate to have the opportunity to collaborate with Professor Papini and the PeptLab team.” said Torben Jörgensen, President and CEO of Biotage AB, “We are all very excited by the opportunity to work with this prestigious group and are looking forward to our collaboration across a wide range of activities.”

Prof. Papini remarked that “It is evident that the cooperation with Biotage fits perfectly with our goals both within PeptLab itself and the wider framework of the European Innovation Network. It is for this reason that we decided to invest in the Biotage Syro II and Syro Wave® parallel peptide synthesizers for our SOSCO Laboratory in Cergy-Pontiose. These innovative tools allow us to significantly increase our peptide production as well as provide access the more challenging peptides via the microwave heating capability of the Syro Wave®. Such state-of-the-art equipment, along with a strong commitment not only in research, but also to education and technology transfer are characteristics of the PeptLab life and the collaboration with Biotage”.

For more information on the Biotage Peptide Purification and Synthesis products, please email product_info@biotage.com or visit http://www.biotage.com/peptides

For more information regarding the Laboratory of Peptide and Protein Chemistry and Biology (PeptLab), visit http://www.unifi.it/peptlab.

About Biotage

Biotage offers solutions, knowledge and experience in the areas of analytical chemistry and medicinal chemistry. The customers include the world’s largest pharmaceutical and biotech companies, and leading academic institutes. The company is headquartered in Uppsala with subsidiaries in the US, UK and Japan. Biotage has 272 employees and sales of 428.9 MSEK in 2010. Biotage is listed on the NASDAQ OMX Nordic Stockholm stock exchange. Website: http://www.biotage.com.

For further press information at Biotage please contact:
Rob Thompson, Director of Marketing Communications
10430 Harris Oaks Blvd., Suite C, Charlotte, NC USA 28269
Tel: +1 704 654 4847
Fax: +1 704 654 4917
Email: rob.thompson@biotage.com
Web: http://www.biotage.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Biotage Announces Peptide Research Collaboration with the Laboratory of Peptide and Protein Chemistry and Biology in Florence, Italy here

News-ID: 177719 • Views: 1279

More Releases from Biotage

Biotage® Announces EVOLUTE® EXPRESS Columns - Simplified, Fast and Efficient S …
Uppsala, Sweden -- Biotage® (STO: BIOT), a leading global supplier of solutions and technology for analytical and medicinal chemistry, announces the addition of new polymer based SPE columns to their tried and tested EVOLUTE® EXPRESS range. EVOLUTE® EXPRESS is a novel family of plates, and now columns, that simplify polymer-based SPE by employing a streamlined three step protocol; Load-Wash-Elute. By using this approach and removing the conditioning and equilibration steps, necessary
Biotage Launches ACI™ - Accelerated Chromatographic Isolation
Uppsala, Sweden (July 10, 2014) -- Biotage (STO: BIOT), a leading global supplier of solutions and technology for analytical, medicinal and peptide chemistry, announces the launch of ACI™ (Accelerated Chromatographic Isolation), a new advance converting simple flash purification into a faster and more economical way to isolate pure compounds. Biotage believes that ACI™ will radically improve the efficiency of the laboratory, embracing the latest developments in purification technology to guide chemists
Biotage Breaks New Ground with Its Fully Integrated Mass Directed Flash System
Uppsala, Sweden, June 5, 2013 -- Biotage (STO: BIOT), a leading global supplier of solutions and technology for analytical, medicinal and peptide chemistry, announces the launch of the new Isolera™ Dalton - a fully automated miniaturized mass directed flash purification system. The new system raises the bar for flash purification by integrating, for the first time, a miniaturized mass detector and an advanced flash chromatography system into one commercially available
Biotage Unveils New Fully Automated Microwave Peptide Synthesizer
Uppsala, Sweden, September 25, 2012 -- Biotage® (STO: BIOT), a leading global supplier of solutions and technology for analytical, medicinal and peptide chemistry, introduced an innovative new synthesis platform for peptide researchers at the 2012 European Peptide Symposium in Athens, Greece. The Biotage® Initiator+ Alstra is a fully automated, single channel, programmable microwave peptide synthesizer and is the latest addition to Biotage's growing family of peptide synthesis platforms. The Initiator+ Alstra

All 5 Releases